詹頂立

職稱主治醫師

專長一般放射腫瘤、攝護腺癌、泌尿道腫瘤、食道癌、消化系統癌
學歷1997~2004 國立成功大學醫學院醫學系
經歷2006~2010 林口長庚紀念醫院放射腫瘤科 住院醫師
2010~2016 林口長庚紀念醫院放射腫瘤科 主治醫師
2016~2020 基隆長庚紀念醫院放射腫瘤科 主任
2020~ 林口長庚紀念醫院放射腫瘤科 主治醫師


參與學會台灣放射腫瘤學會
發表論文Publications
  • Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy. Lin YH, Huang SM, Yap WK, Yang JW, Yeung L, Tsan DL, Chang JT, Chen LC. Radiat Oncol. 2020 Jun 22;15(1):156. 
  • Maintenance of multi-domain neurocognitive functions in patients with newly-diagnosed primary CNS lymphoma after primary cranial radiotherapy combined with methotrexate-based chemotherapy: A preliminary case-series study. Lin SY, Chuang CC, Tsan DL, Hung YS, Fu CJ, Shen YL, Chiang YY, Huang YC, Lu YJ, Yang CC. Appl Neuropsychol Adult. 2020 Apr 17:1-10. 
  • Optimal Timing for Postsurgical Adjuvant Therapy in Patients with Gastric Cancer: A Propensity Score Matching Study. Huang SM, Chen YC, Chen WY, Yang LY, Tsan DL, Tsang NM, Yap WK, Tsai CS, Leung WM, Hong JH, Chang JT, Yeh TS, Wu TH, Chen YC, Lin YH, Huang BS. J Cancer. 2019 Jan 1;10(2):332-340. 
  • Heterogeneity and irregularity of pretreatment 18F-fluorodeoxyglucose positron emission tomography improved prognostic stratification of p16-negative high-risk squamous cell carcinoma of the oropharynx. Cheng NM, Fang YD, Tsan DL, Lee LY, Chang JT, Wang HM, Ng SH, Liao CT, Yang LY, Yen TC. Oral Oncol. 2018 Mar;78:156-162. 
  • Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients. Cheng NM, Fang YH, Tsan DL, Hsu CH, Yen TC. PLoS One. 2016 Mar 1;11(3):e0150509.
  • Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma. Wang HM, Cheng NM, Lee LY, Fang YH, Chang JT, Tsan DL, Ng SH, Liao CT, Yang LY, Yen TC. Int J Cancer. 2016 Feb 1;138(3):731-8. 
  • Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. Cheng NM, Fang YH, Lee LY, Chang JT, Tsan DL, Ng SH, Wang HM, Liao CT, Yang LY, Hsu CH, Yen TC. Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):419-28. 
  • Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC. J Nucl Med. 2013 Oct;54(10):1703-9.
  • Pre-radiotherapy PSA level as a predictor for biochemical control in prostate cancer patients receiving radiotherapy after radical prostatectomy. Tsan DL, Fan KH, Chen YC, Chuang CK, Lee CC, Hong JH. Biomed J. 2013 Mar-Apr;36(2):71-6. 
  • The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Tsan DL, Lin CY, Kang CJ, Huang SF, Fan KH, Liao CT, Chen IH, Lee LY, Wang HM, Chang JT. Radiat Oncol. 2012 Dec 18;7:215.
  • Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC. Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1673-84.